174 related articles for article (PubMed ID: 6708933)
1. Interactions of the antitumor agents mitoxantrone and bisantrene with deoxyribonucleic acids studied by electron microscopy.
Lown JW; Hanstock CC; Bradley RD; Scraba DG
Mol Pharmacol; 1984 Jan; 25(1):178-84. PubMed ID: 6708933
[TBL] [Abstract][Full Text] [Related]
2. Comparative molecular pharmacology in leukemic L1210 cells of the anthracene anticancer drugs mitoxantrone and bisantrene.
Bowden GT; Roberts R; Alberts DS; Peng YM; Garcia D
Cancer Res; 1985 Oct; 45(10):4915-20. PubMed ID: 4027978
[TBL] [Abstract][Full Text] [Related]
3. Electron microscopic observations of the effects of anthraquinone derivatives on plasmid DNA.
Morier-Teissier E; Bernier JL; Coulaud D; Hénichart JP; Delain E
J Biomol Struct Dyn; 1992 Feb; 9(4):653-66. PubMed ID: 1616624
[TBL] [Abstract][Full Text] [Related]
4. Interaction of bisantrene anti-cancer agents with DNA: footprinting, structural requirements for DNA unwinding, kinetics and mechanism of binding and correlation of structural and kinetic parameters with anti-cancer activity.
Elliott JA; Wilson WD; Shea RG; Hartley JA; Reszka K; Lown JW
Anticancer Drug Des; 1989 Mar; 3(4):271-82. PubMed ID: 2539168
[TBL] [Abstract][Full Text] [Related]
5. Conformational drug determinants of the sequence specificity of drug-stimulated topoisomerase II DNA cleavage.
Capranico G; Palumbo M; Tinelli S; Mabilia M; Pozzan A; Zunino F
J Mol Biol; 1994 Jan; 235(4):1218-30. PubMed ID: 8308885
[TBL] [Abstract][Full Text] [Related]
6. Mode and kinetics of DNA binding of the anti-tumour agent bisantrene.
Denny WA; Wakelin LP
Anticancer Drug Des; 1987 Aug; 2(1):71-7. PubMed ID: 3449086
[TBL] [Abstract][Full Text] [Related]
7. Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity.
Gatto B; Zagotto G; Sissi C; Cera C; Uriarte E; Palù G; Capranico G; Palumbo M
J Med Chem; 1996 Aug; 39(16):3114-22. PubMed ID: 8759632
[TBL] [Abstract][Full Text] [Related]
8. The binding of the anthelmintic pyrvinium cation to deoxyribonucleic acid in vitro.
Dickie P; Morgan AR; Scraba DG; von Borstel RC
Mol Pharmacol; 1986 Apr; 29(4):427-35. PubMed ID: 3702861
[TBL] [Abstract][Full Text] [Related]
9. Competitive fluorescence polarization study of the binding of 1,4-dihydroxy-5,8-bis[(2-[(2-hydroxyethyl) amino] ethyl]amino] 9-10-anthracenedione to DNA.
Richardson CL; Roboz J; Holland JF
Res Commun Chem Pathol Pharmacol; 1980 Mar; 27(3):497-506. PubMed ID: 7384639
[TBL] [Abstract][Full Text] [Related]
10. [Study of the properties of condensed forms of the complexes of linear and supercoiled DNA with mitoxantrone and bisantrene].
Salianov VI; Evdokimov IuM; Palumbo M
Antibiot Khimioter; 1990 Jan; 35(1):19-22. PubMed ID: 2334240
[TBL] [Abstract][Full Text] [Related]
11. New anthracenedione derivatives with improved biological activity by virtue of stable drug-DNA adduct formation.
Mansour OC; Evison BJ; Sleebs BE; Watson KG; Nudelman A; Rephaeli A; Buck DP; Collins JG; Bilardi RA; Phillips DR; Cutts SM
J Med Chem; 2010 Oct; 53(19):6851-66. PubMed ID: 20860366
[TBL] [Abstract][Full Text] [Related]
12. Comparative cytotoxicity of bisantrene, mitoxantrone, ametantrone, dihydroxyanthracenedione, dihydroxyanthracenedione diacetate, and doxorubicin on human cells in vitro.
Drewinko B; Yang LY; Barlogie B; Trujillo JM
Cancer Res; 1983 Jun; 43(6):2648-53. PubMed ID: 6850582
[TBL] [Abstract][Full Text] [Related]
13. Effects of 9,10-anthracenedione, 1,4-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-, diacetate on cell morphology and nucleic acids of friend leukemia cells.
Evenson DP; Traganos F; Darzynkiewicz Z; Staiano-Coico L; Melamed MR
J Natl Cancer Inst; 1980 Apr; 64(4):857-66. PubMed ID: 6928997
[TBL] [Abstract][Full Text] [Related]
14. Sequence selectivity of topoisomerase II DNA cleavage stimulated by mitoxantrone derivatives: relationships to drug DNA binding and cellular effects.
De Isabella P; Capranico G; Palumbo M; Sissi C; Krapcho AP; Zunino F
Mol Pharmacol; 1993 May; 43(5):715-21. PubMed ID: 8388987
[TBL] [Abstract][Full Text] [Related]
15. Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.
Alberts DS; Mackel C; Pocelinko R; Salmon SE
Cancer Res; 1982 Mar; 42(3):1170-5. PubMed ID: 7037174
[TBL] [Abstract][Full Text] [Related]
16. Interactions of a new antitumor antibiotic BBM-928A with deoxyribonucleic acid. Bifunctional intercalative binding studied by fluorometry and viscometry.
Huang CH; Mong S; Crooke ST
Biochemistry; 1980 Nov; 19(24):5537-42. PubMed ID: 7459330
[TBL] [Abstract][Full Text] [Related]
17. Electron and scanning force microscopy studies of alterations in supercoiled DNA tertiary structure.
Cherny DI; Jovin TM
J Mol Biol; 2001 Oct; 313(2):295-307. PubMed ID: 11800558
[TBL] [Abstract][Full Text] [Related]
18. Spectroscopic studies of the effects of anticancer drug mitoxantrone interaction with calf-thymus DNA.
Agarwal S; Jangir DK; Mehrotra R
J Photochem Photobiol B; 2013 Mar; 120():177-82. PubMed ID: 23266050
[TBL] [Abstract][Full Text] [Related]
19. Effects of DNA superhelical changes induced by ethidium bromide on the DNA-degrading activity of two antitumor antibiotics, bleomycin and phleomycin.
Huang CH; Mirabelli CK; Mong S; Crooke ST
Cancer Res; 1983 Jun; 43(6):2849-56. PubMed ID: 6189587
[TBL] [Abstract][Full Text] [Related]
20. Effects of Na+ and Mg2+ on the structures of supercoiled DNAs: comparison of simulations with experiments.
Gebe JA; Delrow JJ; Heath PJ; Fujimoto BS; Stewart DW; Schurr JM
J Mol Biol; 1996 Sep; 262(2):105-28. PubMed ID: 8831783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
